Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

Meet an Expert

For these students, medical school is a family affair
8/3/23
Three pairs of twins — plus another pair of siblings — are among the 184 students in the Jacobs School’s Class of 2027.
With her first R01, junior faculty member at UB is exploring what drives drug resistance in prostate cancer
8/1/23
After a successful fellowship at the National Cancer Institute, Adelaiye-Ogala chose to continue her career at UB, attracted by Buffalo’s diversity and energy.
A clinic in Buffalo is detecting—and treating—hepatitis C virus in infants
7/26/23
A new paper documents the successes of a UB-led clinic that is screening and treating HCV in exposed infants.
Jacobs School student gets to work with the Buffalo Bills’ medical team this summer
7/19/23
A UB medical student is one of just 19 students nationwide who will participate in the NFL's Diversity in Sports Medicine Pipeline Initiative.
UB lab identifies key enzyme for heart failure drug digoxin
7/17/23
The discovery could help reduce the plant-based drug’s three-year production time; lead to less toxic alternatives.
UB, partner awarded $3 million NIH grant to study immune cell therapy for tumors
7/12/23
The work could improve a promising type of immunotherapy treatment — chimeric antigen receptor (CAR) T-cell therapy.
Study: Pain risk varies significantly across states
7/7/23
The risk of joint pain is over three times higher in some states compared to others, with states in the South having particularly high prevalence of joint pain.
Susan Grinslade named American Academy of Nursing fellow
7/6/23
Grinslade’s work addresses health disparities and social determinants of health among underserved populations.
Media Advisory: High schoolers to probe stream water for genetic material at UB workshop
6/27/23
The scientific sleuthing is one of many activities planned at the Eric Pitman Annual Summer Workshop in Computational Science.
UB professor headed group that wrote AHA's first treatment statement for pediatric cardiomyopathy
6/22/23
Steven E. Lipshultz, MD, chaired the writing group that developed the statement, a companion to the association’s 2019 scientific statement focused on diagnosing the condition, an effort that Lipshultz also chaired.